Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Clinicopathological Significance of Immunoexpression of Claudin-1 and Claudin-7 in Feline Mammary Carcinomas
Publication

Publications

Clinicopathological Significance of Immunoexpression of Claudin-1 and Claudin-7 in Feline Mammary Carcinomas

Title
Clinicopathological Significance of Immunoexpression of Claudin-1 and Claudin-7 in Feline Mammary Carcinomas
Type
Article in International Scientific Journal
Year
2014
Authors
Dias Pereira P
(Author)
ICBAS
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Flores AR
(Author)
Other
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications Without AUTHENTICUS Without ORCID
Rema A
(Author)
ICBAS
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications Without AUTHENTICUS Without ORCID
Carvalho F
(Author)
ICBAS
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications Without AUTHENTICUS Without ORCID
lopes, g
(Author)
ICBAS
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Augusto Faustino
(Author)
ICBAS
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications Without AUTHENTICUS View ORCID page
Journal
Vol. 151
Pages: 339-346
ISSN: 0021-9975
Publisher: Elsevier
Other information
Authenticus ID: P-00A-5QQ
Abstract (EN): Claudins (CLDNs) are tight junction proteins that have a role in regulating cell adhesion and polarity, paracellular permeability, proliferation and differentiation. Several immunohistochemical studies have shown reduced expression of CLDN-1 and CLDN-7 in human and canine mammary carcinomas, suggesting that these proteins may participate in mammary carcinogenesis, invasion and metastasis. The present study characterizes expression of CLDN-1 and CLDN-7 in feline mammary carcinomas (n = 52) and their metastases (n = 29). There was an inverse association between CLDN-7 expression and histological grade of tumour. Reduced expression of CLDN-7 was significantly associated with decreased tubule formation, high proliferative activity and metastasis. No significant associations were found between CLDN-1 expression and any of these features. Evaluation of expression of CLDN-7, but not CLDN-1, may therefore provide prognostic information, assisting in the diagnosis of a subgroup of aggressive feline mammary carcinomas that share some features with the recently described 'claudin-low' subgroup of human breast cancer.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 8
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Canine Gastric Pathology: A Review (2016)
Another Publication in an International Scientific Journal
Amorim, I; Taulescu, MA; Day, MJ; Catoi, C; Celso Reis; Carneiro F; Gaertner, F
Solid Carcinoma of the Canine Mammary Gland: a Histological Type or Tumour Cell Arrangement? (2022)
Article in International Scientific Journal
Nakagaki, KY; Nunes, MM; Garcia, APV; Nunes, FC; Fernando Schmitt; Cassali, GD
Single Nucleotide Polymorphisms Influence Histological Type and Grade of Canine Malignant Mammary Tumours (2019)
Article in International Scientific Journal
Canadas Sousa, A; Santos, M; Rui Medeiros; Dias Pereira, P
Reduced expression of claudin-2 is associated with high histological grade and metastasis of feline mammary carcinomas. (2014)
Article in International Scientific Journal
Dias Pereira P; Rema A; Carvalho F; Augusto Faustino; Flores AR

See all (20)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-13 at 14:13:05 | Privacy Policy | Personal Data Protection Policy | Whistleblowing